A novel mifepristone-loaded implant for long-term treatment of endometriosis: In vitro and in vivo studies
article
OA: closed
CC0
⤵ 21 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
Researchers developed and tested a novel mifepristone-loaded implant in vitro and in vivo for potential long-term treatment of endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (36)
- Changing concepts of medical treatment of endometriosis via openalex
- Clinical applications of mifepristone via openalex
- Dose-Response Relationships of RU 486 via openalex
- Emerging drugs for endometriosis via openalex
- Endocrine responses to long-term administration of the antiprogesterone RU486 in patients with pelvic endometriosis via openalex
- Pharmacokinetics of mifepristone after low oral doses via openalex
- Placebo-controlled comparison of hormonal and biochemical effects of danazol and high-dose medroxyprogesterone acetate via openalex
- Progestins for symptomatic endometriosis: a critical analysis of the evidence via openalex
- The effect of a luteinizing hormone releasing hormone (LRH) agonist (Wy-40,972), levonorgestrel, danazol and ovariectomy on experimental endometriosis in the rat via openalex
- The evidence for the management of endometriosis via openalex
- Treatment of Endometriosis via openalex
- W2032032896 via openalex
- W2049361628 via openalex
- W2059815320 via openalex
- W2066780190 via openalex
- W2073233871 via openalex
- W2093512443 via openalex
- W2112616379 via openalex
- W2113220146 via openalex
- W2120060289 via openalex
- W2124195334 via openalex
- W2291477050 via openalex
- W2293158529 via openalex
- W2322133447 via openalex
- W94893961 via openalex
- W6603850209 via openalex
- W653459322 via openalex
- W1512318310 via openalex
- W1525837605 via openalex
- W1555994455 via openalex
- W1910306760 via openalex
- W1965956016 via openalex
- W1983057866 via openalex
- W2022212009 via openalex
- W2024095117 via openalex
- W2030681105 via openalex
Cited by (21)
- Uterine Drug-Delivery Systems 2026
- Treatment of endometriosis with mifepristone mediated by nanostructured lipid carriers 2024
- Progesterone receptor ligands for the treatment of endometriosis 2022
- Endometrial Stem Cells and Endometriosis 2022
- New Therapeutics in Endometriosis: A Review of Hormonal, Non-Hormonal, and Non-Coding RNA Treatments 2021
- Progesterone receptor ligands for the treatment of endometriosis: the mechanisms behind therapeutic success and failure 2020
- Endometriosis and nuclear receptors 2019
- Progressive Fibrosis: A Progesterone- and KLF11-Mediated Sexually Dimorphic Female Response 2017
- New developments in the medical treatment of endometriosis 2017
- Hormonal therapy for endometriosis: from molecular research to bedside 2016
- Mifepristone 2.5, 5, 10mg versus placebo in the treatment of endometriosis 2015
- Emerging therapy for endometriosis 2015
- Innovations in classical hormonal targets for endometriosis 2015
- The influence of mifepristone to caspase 3 expression in adenomyosis 2014
- Medical Treatments for Endometriosis-Associated Pelvic Pain 2014
- Novel agents for the medical treatment of endometriosis 2014
- Antiprogestins in gynecological diseases 2014
- Intérêt actuel des selective progesterone receptor modulators (SPRM) dans l’endométriose 2013
- The immninent dawn of SPRMs in obstetrics and gynecology 2012
- Effect of mifepristone on COX-2 both in eutopic and ectopic endometrium in mouse endometriotic model 2012
- Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety 2011
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:17:18.915199+00:00
License: CC0
· commercial use OK